NASDAQ
Total Transactions
61
21 buys /40 sells
Shares Acquired
116,643
Transactions: 21•Avg: 5,554.43
Shares Disposed
218,679
Transactions: 40•Avg: 5,466.98
Net Activity
-102,036
Net Selling•Ratio: 52.5%
Q4 2025(Current) | 116,643 | 218,679 | -102,036 | 52.50% |
Q3 2025 | 56,033 | 104,117 | -48,084 | 36.36% |
Q2 2025 | 30,755 | 40,130 | -9,375 | 72.92% |
Q1 2025 | 199,832 | 214,611 | -14,779 | 58.70% |
Q4 2024 | 69,146 | 134,875 | -65,729 | 56.52% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 102,036 shares•Acquired/Disposed Ratio: 52.5%
Net Activity | |||||
|---|---|---|---|---|---|
GGS GUTHART GARY S | Director, officer: executive chair of the board o | 17 | 105,393 | 210,352 | -104,959 |
RDJ Rosa David J. | Director, officer: chief executive officer (ceo) | 9 | 35,998 | 59,837 | -23,839 |
CHL Charlton Henry L | Officer: evp & chief commercial and mkt | 10 | 9,000 | 16,632 | -7,632 |
CM Curet Myriam | Officer: evp & chief medical officer | 22 | 12,521 | 18,859 | -6,338 |
BCH BARRATT CRAIG H | Director | 6 | 2,943 | 5,886 | -2,943 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-10 | Officer: evp & chief medical officer | Sale | 104 | $229.39 | $23,856.56 | 1,467 | |
2025-12-10 | Officer: evp & chief medical officer | Purchase | 104 | $229.39 | $23,856.56 | 104 | |
2025-12-10 | Officer: evp & chief medical officer | Sale | 104 | $559.9 | $58,229.6 | - | |
2025-12-01 | Officer: evp & chief medical officer | Sale | 125 | $208.9 | $26,112.5 | 376 | |
2025-12-01 | Officer: evp & chief medical officer | Purchase | 125 | $208.9 | $26,112.5 | 125 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
CM Curet Myriam | Officer: evp & chief medical officer | Dec 10, 2025 | |
CM Curet Myriam | Officer: evp & chief medical officer | Dec 10, 2025 | |
CM Curet Myriam | Officer: evp & chief medical officer | Dec 10, 2025 | |
CM Curet Myriam | Officer: evp & chief medical officer | Dec 2, 2025 | |
CM Curet Myriam | Officer: evp & chief medical officer | Dec 2, 2025 |
Net change in shares shown on right
No price data available for this timeframe.